Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 2 (February)

1. Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
   J Gastroenterol Hepatol, 20(2): 256-63. [Abstract] [Full-text]
2. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
   Biochem J, 386: 35-45. [Abstract] [Full-text]
3. Benign schwannoma of the pancreas.
   J Gastrointest Surg, 9(2): 288-90. [Abstract] [Full-text]
4. Hypercalcemia and pancreatic endocrine neoplasia with elevated PTH-rP: report of two new cases and subject review.
   J Gastrointest Surg, 9(2): 270-9. [Abstract] [Full-text]
5. Resection of a cancer developing in the remnant pancreas after a pancreaticoduodenectomy for pancreas head cancer.
   J Gastrointest Surg, 9(2): 263-9. [Abstract] [Full-text]
6. Peripancreatic tuberculosis mimicking pancreatic neoplasia.
   J Gastrointest Surg, 9(2): 254-62. [Abstract] [Full-text]
7. The role of splenomesenteric vein anastomosis after division of the splenic vein in pancreatoduodenectomy.
   J Gastrointest Surg, 9(2): 245-53. [Abstract] [Full-text]
8. Case report: serial percutaneous cholangioscopy with laser ablation for the management of locally recurrent biliary intraductal papillary mucinous tumor.
   J Gastrointest Surg, 9(2): 215-8. [Abstract] [Full-text]
9. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
   Pathol Int, 55(2): 63-9. [Abstract] [Full-text]
10. Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion.
    J Biol Chem, 280(6): 4992-5003. [Abstract] [Full-text]
11. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Eur J Surg Oncol, 31(2): 164-9. [Abstract] [Full-text]
12. A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma.
    Br J Cancer, 92(3): 445-8. [Abstract] [Full-text]
13. Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes.
    Br J Cancer, 92(2): 405-12. [Abstract] [Full-text]
14. Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.
    Br J Cancer, 92(1): 21-3. [Abstract] [Full-text]
15. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.
    Br J Cancer, 92(1): 94-101. [Abstract] [Full-text]
16. Endostatin expression in pancreatic tissue is modulated by elastase.
    Br J Cancer, 92(1): 89-93. [Abstract] [Full-text]
17. Diabetes mellitus: a risk factor for pancreatic cancer?
    Langenbecks Arch Surg, 390(1): 66-72. [Abstract] [Full-text]
18. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.
    Gut, 54(3): 385-7. [Abstract] [Full-text]
19. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells.
    Int J Cancer, 114(4): 522-30. [Abstract] [Full-text]
20. Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
    J Clin Oncol, 23(6): 1228-36. [Abstract] [Full-text]
21. Effects of growth regulation on conditionally-transformed alginate-entrapped insulin secreting cell lines in vitro.
    Biomaterials, 26(22): 4633-41. [Abstract] [Full-text]
22. Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
    Nucl Med Biol, 32(2): 137-45. [Abstract] [Full-text]
23. Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line.
    Cancer Genet Cytogenet, 157(2): 109-17. [Abstract] [Full-text]
24. Nonstandard pancreatic resections for unusual lesions.
    Am J Surg, 189(2): 223-8. [Abstract] [Full-text]
25. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
    Neoplasia, 7(1): 17-23. [Abstract] [Full-text]
26. Monoclonal antibody 16D10 to the C-terminal domain of the feto-acinar pancreatic protein binds to membrane of human pancreatic tumoral SOJ-6 cells and inhibits the growth of tumor xenografts.
    Neoplasia, 6(6): 713-24. [Abstract] [Full-text]
27. Surgical treatment of non-functioning pancreatic islet cell tumors.
    J Surg Oncol, 89(3): 170-85. [Abstract] [Full-text]
28. Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma.
    Cancer, 103(5): 1026-35. [Abstract] [Full-text]
29. Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.
    Mol Ther, 11(3): 363-72. [Abstract] [Full-text]
30. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    J Magn Reson Imaging, 21(3): 237-44. [Abstract] [Full-text]
31. Dietary patterns and risk of pancreatic cancer.
    Int J Cancer, 114(5): 817-23. [Abstract] [Full-text]
32. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts.
    Cancer Res, 65(4): 1497-504. [Abstract] [Full-text]
33. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
    Cancer Res, 65(4): 1316-24. [Abstract] [Full-text]
34. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.
    Cancer Epidemiol Biomarkers Prev, 14(2): 459-66. [Abstract] [Full-text]
35. Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
    Cancer Detect Prev, 29(1): 8-14. [Abstract] [Full-text]
36. DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.
    J Biol Chem, 280(9): 7962-75. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.